Active ingredient
- dexmedetomidine hydrochloride
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 27925/0104.
Dexdor 100 micrograms/ml concentrate for solution for infusion
Package leaflet: Information for the user
Dexdor 100 micrograms/ml concentrate for solution for infusion
dexmedetomidine
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
What is in this leaflet
1. What Dexdor is and what it is used for
2. What you need to know before you are given Dexdor
3. How to use Dexdor
4. Possible side effects
5. How to store Dexdor
6. Contents of the pack and other information
1. What Dexdor is and what it is used for
Dexdor contains an active substance called dexmedetomidine which belongs to a medicine group called sedatives. It is used to provide sedation (a state of calm, drowsiness or sleep) for adult patients in hospital intensive care settings or awake sedation during different diagnostic or surgical procedures.
2. What you need to know before you are given Dexdor
You must not be given Dexdor
Warnings and precautions
Before you have this medicine, tell your doctor or nurse if any of the following apply as Dexdor should be used cautiously:
Other medicines and Dexdor
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.
The following medicines may enhance the effect of Dexdor:
If you are using medicines which lower your blood pressure and heart rate, co-administration with Dexdor may enhance this effect. Dexdor should not be used with medicines that cause temporary paralysis.
Pregnancy and breast-feeding
Dexdor should not be used during pregnancy or breast-feeding unless clearly necessary.
Ask your doctor for advice before having this medicine
Driving and using machines
Dexdor has major impact on the ability to drive and use machines. After you have been given Dexdor you must not drive, operate machinery, or work in dangerous situations until the effects are completely gone. Ask your doctor when you can start doing these activities again and when you can go back to this kind of work.
Excipients
Dexdor contains less than 1 mmol sodium (23 mg) per ml, that is to say essentially ‘sodium-free’.
3. How to use Dexdor
Hospital intensive care
Dexdor is administered to you by a doctor or nurse in hospital intensive care.
Procedural sedation/awake sedation
Dexdor is administered to you by a doctor or a nurse prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation.
Your doctor will decide on a suitable dose for you. The amount of Dexdor depends on your age, size, general condition of health, the level of sedation needed and how you respond to the medicine. Your doctor may change your dose if needed and will monitor your heart and blood pressure during the treatment.
Dexdor is diluted and it is given to you as an infusion (drip) into your veins.
After sedation/wake-up
If you have been given more Dexdor than you should
If you are given too much Dexdor, your blood pressure may go up or down, your heartbeat may slow down, you may breathe more slowly and you may feel more drowsy. Your doctor will know how to treat you based on your condition.
If you have any further questions on the use of this medicine, ask your doctor.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (affects more than 1 user in 10)
Common (affects 1 to 10 users in 100)
Uncommon (affects 1 to 10 users in 1,000)
Not known (frequency cannot be estimated from the available data)
Reporting of side effects
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Dexdor
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton after EXP.
This medicine does not require any special temperature storage conditions. Keep the ampoules or vials in the outer carton in order to protect from light.
6. Contents of the pack and other information
What Dexdor contains
Each 2 ml ampoule contains 200 micrograms of dexmedetomidine (as hydrochloride).
Each 2 ml vial contains 200 micrograms of dexmedetomidine (as hydrochloride).
Each 4 ml vial contains 400 micrograms of dexmedetomidine (as hydrochloride).
Each 10 ml vial contains 1000 micrograms of dexmedetomidine (as hydrochloride).
The concentration of the final solution after dilution should be either 4 micrograms/ml or 8 micrograms/ml.
What Dexdor looks like and contents of the pack
Concentrate for solution for infusion (sterile concentrate).
The concentrate is a clear, colourless solution.
Containers
2 ml glass ampoules
2, 5 or 10 ml glass vials
Pack sizes
5 x 2 ml ampoules
25 x 2 ml ampoules
5 x 2 ml vials
4 x 4 ml vials
4 x 10 ml vials
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
This leaflet was last revised in
January 2021.
Abbey Gardens, 4 Abbey Street, Reading, RG1 3BA, UK
+44 (0)1635 520 300
+44 (0)1635 520 300